We are live on ! Find out more
GDP

Great Diamond Partners Portfolio holdings

AUM $582M
1-Year Est. Return 26.87%
This Fund
S&P 500
This Quarter Est. Return
+20.68%
1 Year Est. Return
+26.87%
3 Year Est. Return
+78.61%
5 Year Est. Return
+97.56%
10 Year Est. Return
AUM
$242M
AUM Growth
+$47.3M
Cap. Flow
+$10.4M
Cap. Flow %
4.3%
Top 10 Hldgs %
44.18%
Holding
155
New
29
Increased
57
Reduced
55
Closed
8

Top Sells

Rank Stock Value
1
CB icon
Chubb
CB
+$1.23M
2
PFE icon
Pfizer
PFE
+$1.15M
3
AMGN icon
Amgen
AMGN
+$1.04M
4
JPM icon
JPMorgan Chase
JPM
+$787K
5
IWV icon
iShares Russell 3000 ETF
IWV
+$584K

Sector Composition

Rank Sector Weight
1 Healthcare 15.01%
2 Technology 13.06%
3 Industrials 5.59%
4 Consumer Staples 5.45%
5 Consumer Discretionary 5.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IAI icon
151
iShares US Broker-Dealers & Securities Exchanges ETF
IAI
$1.36B
-5,027
Closed -$257K
IHF icon
152
iShares US Healthcare Providers ETF
IHF
$1.21B
-7,645
Closed -$254K
NVO
153
Novo Nordisk
NVO
$208B
-12,460
Closed -$375K
WFC icon
154
Wells Fargo
WFC
$261B
-10,892
Closed -$312K
XLU icon
155
State Street Utilities Select Sector SPDR ETF
XLU
$22.8B
-10,902
Closed -$302K

Similar funds

Great Diamond Partners's Q2 2020 Portfolio in Review

As of Q2 2020, Great Diamond Partners held 155 positions worth $242M, up 24% from $194M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Great Diamond Partners deployed $10.4M of net new capital in Q2 2020, opening 29 new positions and adding to 57 existing holdings. Its largest new stake was Invesco QQQ Trust: 29,011 shares worth $7.18M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Pfizer, an estimated $1.15M trimmed.

  • Great Diamond Partners's largest Q2 2020 buy was Invesco QQQ Trust: 29,011 shares worth $7.18M.
  • Great Diamond Partners added most to Air Products & Chemicals in Q2 2020, an estimated $1.17M increase.
  • Great Diamond Partners's biggest Q2 2020 reduction was Pfizer, cutting an estimated $1.15M.
  • Great Diamond Partners fully exited Chubb in Q2 2020, selling an estimated $1.23M.
  • Great Diamond Partners's ten largest holdings make up 44% of its $242M portfolio in Q2 2020.
  • Great Diamond Partners opened 29 new positions and closed 8 in Q2 2020.
  • Great Diamond Partners's portfolio value rose 24% quarter-over-quarter to $242M.

Based on Great Diamond Partners's 13F filing for Q2 2020, filed 4 Aug 2020.